Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccinePfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine
    Coronavirus: Govt puts immediate ban on Export of  Masks, Ventilators and textile raw material for masks and coverallsCoronavirus: Govt puts immediate ban on Export of Masks, Ventilators and textile raw material for...
    Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its standIbuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand
    CDSCO issues clarification on the requirement of process validation report for permission to conduct Clinical trial/BA-BE studiesCDSCO issues clarification on the requirement of process validation report for permission to conduct...
    Merck Announces positive results for Gefapixant  Phase 3 Trial to treat Chronic CoughMerck Announces positive results for Gefapixant Phase 3 Trial to treat Chronic Cough
    AstraZenecas Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patientsAstraZeneca's Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for...
    Dr Reddys Labs launches Naloxone Hydrochloride Injection in US MarketDr Reddy's Labs launches Naloxone Hydrochloride Injection in US Market
    Prices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities ActPrices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities Act
    Dr Reddys Labs launches Pyrimethamine Tablets in USDr Reddy's Labs launches Pyrimethamine Tablets in US
    API should be declared strategic sector especially in light of Coronavirus: CIIAPI should be declared strategic sector especially in light of Coronavirus: CII
    Abbott gets USFDA emergency use authorization for COVID-19 molecular testAbbott gets USFDA emergency use authorization for COVID-19 molecular test
    Roche Diagnostics India first private firm to get COVID-19 test approvalRoche Diagnostics India first private firm to get COVID-19 test approval
    PrevNext

    Popular Stories

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok